Key Findings:  In rats, cannabigerol (CBG) produced potent inflammatory effects in this model of diabetic kidney disease (DKD) development.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  Poland
Year of Pub:  2025
Cannabinoids Studied:  Cannabigerol (CBG)
Phytocannabinoid Source:  Not Applicable
Ligands Studied:  Pro-inflammatory cytokines
Route of Administration:  Oral (Ingestion)
Citation:  Stepaniuk A, Sztolsztener K, Konstantynowicz-Nowicka K, Harasim-Symbor E, Bielawiec P, Chabowski A. The Identification of Novel Anti-Inflammatory Effects of Cannabigerol in the Kidney Tissue of Rats Subjected to a High-Fat High-Sucrose Diet. Int J Mol Sci. 2025 Mar 28;26(7):3114. doi: 10.3390/ijms26073114. PMID: 40243749; PMCID: PMC11988375.